{"role": "assistant", "content": null, "function_call": {"name": "get_risks", "arguments": "{\"risks\":[{\"Description\":\"Spectrum bias perpetuates the inability to distinguish COVID-19 from illnesses with similar presentations.\",\"Impact\":\"Increase in misdiagnosis and delay in treatment for contagious diseases.\",\"Mitigation\":\"Implement data augmentation techniques to counteract the spectrum bias.\",\"Technologies\":\"Data augmentation algorithms, machine learning models.\",\"People\":\"Healthcare professionals, patients with contagious diseases.\",\"Owner\":\"Healthcare institutions, data scientists.\"},{\"Description\":\"Small sample sizes increase the effect of overfitting in validation methods.\",\"Impact\":\"Inaccurate performance evaluation of wearable technology for contagious disease detection.\",\"Mitigation\":\"Use external validation methods and increase sample sizes for more accurate performance assessment.\",\"Technologies\":\"External validation techniques, data augmentation, big data analytics.\",\"People\":\"Healthcare researchers, data scientists.\",\"Owner\":\"Healthcare institutions, research organizations.\"},{\"Description\":\"ADM performance may be overoptimistic due to overfitting and lack of generalizability.\",\"Impact\":\"False reassurance to infectious individuals and poor performance in real-world settings.\",\"Mitigation\":\"Implement external validation and focus on device-agnostic ADMs for better generalizability.\",\"Technologies\":\"External validation techniques, machine learning algorithms.\",\"People\":\"Healthcare professionals, infectious individuals.\",\"Owner\":\"Healthcare institutions, data scientists.\"}]}"}}